Skip to content

Development and Efficacy Analysis of a Line Chart for Predicting the Risk of Depression after Coronary Stent Implantation in Patients with Acute Coronary Syndrome (ACS): A Prospective Cohort Study

Development and Efficacy Analysis of a Line Chart for Predicting the Risk of Depression after Coronary Stent Implantation in Patients with Acute Coronary Syndrome (ACS): A Prospective Cohort Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071408
Enrollment
Unknown
Registered
2023-05-15
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cute coronary syndrome

Interventions

Depression group:None

Sponsors

Fujian Provincial Hospital;Shengli Clinical Medical College of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) successful coronary stent implantation; (2) aged between 30-80 years old; (3) preoperative PHQ-9 score <=4. All participants or their legal guardians provided informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) previous malignant tumor or severe cognitive impairment; (2) a history of mental illness (schizophrenia or schizoaffective disorder (ICD-10: F20.x or F25.x) or bipolar disorder (ICD-10: F31.x); (3) psychopharmacological drugs use within 4 weeks; (4) renal function was evaluated by CKD-EPI equation estimated glomerular filtration rate (eGFR) in patients with renal insufficiency, and renal insufficiency was defined as eGFR< 60 ml/min/1.73m2; (5) taking uric acid-lowering drugs within 1 month.

Design outcomes

Primary

MeasureTime frame
Depression;

Secondary

MeasureTime frame
Uric acid;Total protein;Total bilirubin;High density lipoprotein cholesterol;Urea nitrogen;Creatinine;Fasting blood glucose;Glycosylated hemoglobin (HbA1c%);

Countries

china

Contacts

Public ContactXing Miao

Fujian Provincial Hospital;Shengli Clinical Medical College of Fujian Medical University

182256349@qq.com+86 137 6381 0443

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026